Livongo Blood Glucose Monitoring System (BG1000)— 510(k) K200277

Substantially Equivalent

Livongo Health, Inc.

FDA 510(k) clearance K200277 for Livongo Blood Glucose Monitoring System (BG1000), Substantially Equivalent on 2020-06-04. Applicant: Livongo Health, Inc..

Clearance details

Applicant: Livongo Health, Inc.
Product code: Code NBW
Advisory panel: Clinical Chemistry
Date received: 2020-02-04
Decision date: 2020-06-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mountain View, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code NBW

product code NBW

Death: 18
Injury: 4,740
Malfunction: 42,679
Other: 6
Total: 47,443

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.